Psychedelics have made it to Capitol Hill. On Thursday Congress announced the creation of a Congressional Psychedelics Advancing Clinical Treatments (PACT) Caucus. Led by Representatives Lou Correa (D-CA) and Jack Bergman (R-MI), the caucus will consist of bipartisan members of Congress committed to “addressing ways to alleviate the national mental health crisis through psychedelic science and research.” 

The caucus will not promote or offer recommendations on decriminalization or legalization measures but rather lead the congressional talks on psychedelics as potential therapeutics as well as establish itself as a public educational resource.

As such, the PACT Caucus’ objectives include increasing awareness of psychedelic-assisted therapies (PAT) among members of Congress and their staffs and supporting further federal funding and examining regulatory barriers for psychedelic research and medicine.

The group will hold regular meetings and highlight priorities on behalf of interested members of Congress to external stakeholders and the Executive branch.

The caucus recognizes federal agencies, including those under the National Institutes of Health (NIH), have already put funding toward exploring the therapeutic potential of psychedelics and intends to …

Full story available on